| Product Code: ETC8541986 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Lumasiran Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Lumasiran Market - Industry Life Cycle |
3.4 Netherlands Lumasiran Market - Porter's Five Forces |
3.5 Netherlands Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Netherlands Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Netherlands Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Netherlands Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Netherlands Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases, such as primary hyperoxaluria type 1 (PH1), which lumasiran is used to treat. |
4.2.2 Growing adoption of advanced RNA interference (RNAi) technology in the pharmaceutical industry. |
4.2.3 Favorable government regulations supporting the development and commercialization of orphan drugs in the Netherlands. |
4.3 Market Restraints |
4.3.1 High cost associated with rare disease treatments like lumasiran may limit accessibility for patients. |
4.3.2 Stringent regulatory approval processes for orphan drugs in the Netherlands. |
4.3.3 Competition from alternative treatments or therapies for rare diseases. |
5 Netherlands Lumasiran Market Trends |
6 Netherlands Lumasiran Market, By Types |
6.1 Netherlands Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Netherlands Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Netherlands Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Netherlands Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Netherlands Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Netherlands Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Netherlands Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Netherlands Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Netherlands Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Netherlands Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Netherlands Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Netherlands Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Netherlands Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Netherlands Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Netherlands Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Netherlands Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Netherlands Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Netherlands Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Netherlands Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Netherlands Lumasiran Market Import-Export Trade Statistics |
7.1 Netherlands Lumasiran Market Export to Major Countries |
7.2 Netherlands Lumasiran Market Imports from Major Countries |
8 Netherlands Lumasiran Market Key Performance Indicators |
8.1 Patient enrollment in clinical trials for lumasiran in the Netherlands. |
8.2 Number of healthcare providers trained in prescribing and administering lumasiran. |
8.3 Research and development investment in RNAi technology for rare disease treatments. |
8.4 Patient advocacy group engagement and support for lumasiran therapy. |
9 Netherlands Lumasiran Market - Opportunity Assessment |
9.1 Netherlands Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Netherlands Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Netherlands Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Netherlands Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Netherlands Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Lumasiran Market - Competitive Landscape |
10.1 Netherlands Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here